Home > industry-verticals > healthcare-services > biotechnology > immuno oncology assays market

Immuno Oncology Assays Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DHC226 | Last Updated On: Jan 27 2021 | No. of Pages: 180 | Available Formats

Request free sampleEnquire Before Purchase
> Global Immuno Oncology Assays Market Expected to reach a high CAGR of 12.19% By 2027: DataM Intelligence

Immuno Oncology Assays Market, Size, Share, Opportunities and Forecast, 2020-2027

SKU: DHC226 | Published On: Jan 27 2021 | No. of Pages: 180 | Available Formats

Global Immuno Oncology Assays Market is segmented By Product Type (Consumables, Software), By Technology (Immunoassay, PCR, NGS, Flow Cytometry, others), By Application (Clinical Diagnostics, Research), By Assay type (Cell proliferation assays, Cell migration & invasion assays, Phagocytosis assays, Immune cell killing assays, others), By Indication (Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2020-2027

 

Market Overview

The Global Immuno Oncology Assays Market is expected to grow at a CAGR of 12.19% during the forecasting period (2020-2027).

Why Purchase the Report?

  • Visualize the composition of the Immuno oncology assays Market across each indication, regarding type and treatment options, highlighting the vital commercial assets and players.
  • Identify business opportunities in Immuno oncology assays Market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Immuno oncology assays Market – level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the principal products of all major market players

Target Audience

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

 

Table of Contents

  1. Global Immuno oncology assays Market – Executive Summary

    1. Research methodology

    2. Research Objective and Scope of the Report

  2. Global Immuno oncology assays Market – Market Definition and Overview

  3. Global Immuno oncology assays Market – Executive Summary

    1. Market Snippet by Condition

    2. Market Snippet by Product type

    3. Market Snippet by Technology

    4. Market Snippet by Application

    5. Market Snippet by Assay type

    6. Market Snippet by Indication

  4. Global Immuno oncology assays Market-Market Dynamics

    1. Market Impacting Factors

      1. Drivers

        1. The increasing adoption of targeted therapy over traditional therapy

        2. The increasing demand for mAbs  

        3. The rise in the incidence of cancer

        4. Technological advancements in molecular techniques

        5. Extensive research and development in cancer diagnostics  

      2. Restraints

        1. The high cost of immunotherapy treatment

        2. The high attrition rate in the product development cycle

      3. Impact Analysis

  5. Global Immuno oncology assays Market – Industry Analysis 

    1. Porter's Five Forces Analysis

    2. Supply Chain Analysis  

    3. Regulatory Analysis

    4. Pricing Analysis

    5. Technology Advances

    6. Key Companies to Watch

    7. Epidemiology

  6. Global Immuno oncology assays Market – By Product type

    1. Introduction

    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

    3. Market Attractiveness Index, By Product type

    4. Consumables *

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

    5. Software  

  7. Global Immuno oncology assays Market – By Technology

    1. Introduction

    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), Technology

    3. Market Attractiveness Index, Technology

    4. Immunoassay *

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

    5. PCR

    6. NGS

    7. Flow Cytometry

    8. Other

  8. Global Immuno oncology assays Market – By Application

    1. Introduction

    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), Application

    3. Market Attractiveness Index, Application

    4. Clinical Diagnostics *

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

    5. Research

  9. Global Immuno oncology assays Market – By Assay type

    1. Introduction

    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), Assay type

    3. Market Attractiveness Index, Assay type

    4. Cell proliferation assays *

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

    5. Cell migration & invasion assays

    6. Phagocytosis assays

    7. Immune cell killing assays,

    8. Other

  10. Global Immuno oncology assays Market – By Indication

    1. Introduction

    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), Indication

    3. Market Attractiveness Index, Indication

    4. Colorectal Cancer *

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

    5. Lung Cancer

    6. Melanoma

    7. Bladder Cancer

    8. Others

  11. Global Immuno oncology assays Market – By Region

    1. Introduction  

    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

    3. Market Attractiveness Index, By Region

    4. North America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. The U.S.

        2. Canada

        3. Mexico

    5. Europe

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication

      8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Germany

        2. The U.K.

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

    6. South America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication

      8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Brazil

        2. Argentina

        3. Rest of South America

    7. Asia-Pacific

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication

      8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China

        2. India

        3. Japan

        4. Australia

        5. Rest of Asia Pacific

    8. The Middle East and Africa

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication

  12. Global Market – Competitive Landscape

    1. Competitive Scenario

    2. Competitor Tendinitis Treatment Strategy Analysis

    3. Comparative Product Portfolio Analysis

    4. Market Positioning/Share Analysis

    5. Mergers and Acquisitions Analysis

  13. Company Profiles

    1. Agilent Technologies, Inc.*

      1. Company Overview

      2. Product Portfolio and Description

      3. Key Highlights

      4. Financial Overview

    2. F. Hoffmann-La Roche Ltd

    3. Foundation Medicine, Inc.

    4. HTG Molecular Diagnostics, Inc.

    5. Illumina, Inc.

    6. Merck KGaA

    7. NanoString Technologies, Inc.

    8. PerkinElmer Inc.

    9. Qiagen

    10. Sartorius AG

  14. Global Immuno oncology assays Market – Premium Insights

  15. Global Immuno oncology assays Market – DataM

    1. Appendix

    2. About Us and Services

    3. Contact Us

 

List of Tables & Figures

List of Tables

Table 1            Global Immuno oncology assays Market Value, By Products & Equipment, 2018,2022 & 2027 ($ Million)

Table 2           Global Immuno oncology assays Market Value, By Technology, 2018,2022 & 2027 ($ Million)

Table 3           Global Immuno oncology assays Market Value, By Application, 2018,2022 & 2027 ($ Million)

Table 4           Global Immuno oncology assays Market Value, By Assay type, 2018,2022 & 2027 ($ Million)

Table 5           Global Immuno oncology assays Market Value, By Indication, 2018,2022 & 2027 ($ Million)

Table 6           Global Immuno oncology assays Market Value, By Region, 2018,2022 & 2027 ($ Million)

Table 7           Global Immuno oncology assays Market Value, By Products & Equipment, 2018,2022 & 2027 ($ Million)

Table 8           Global Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)

Table 9           Global Immuno oncology assays Market Value, By Technology, 2018,2022 & 2027 ($ Million)

Table 10         Global Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)

Table 11          Global Immuno oncology assays Market Value, By Application, 2018,2022 & 2027 ($ Million)

Table 12         Global Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)

Table 13         Global Immuno oncology assays Market Value, By Assay type, 2018,2022 & 2027 ($ Million)

Table 14         Global Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)

Table 15          Global Immuno oncology assays Market Value, By Indication, 2018,2022 & 2027 ($ Million)

Table 16         Global Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)

Table 17          Global Immuno oncology assays Market Value, By Region, 2018,2022 & 2027 ($ Million)

Table 18         Global Immuno oncology assays Market Value, By Region, 2017-2027 ($ Million)

Table 19         North America Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)

Table 20         North America Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)

Table 21         North America Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)

Table 22         North America Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)

Table 23         North America Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)

Table 24         North America Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)

Table 25         South America Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)

Table 26         South America Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)

Table 27         South America Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)

Table 28         South America Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)

Table 29         South America Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)

Table 30         South America Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)

Table 31         Europe Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)

Table 32         Europe Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)

Table 33         Europe Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)

Table 34         Europe Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)

Table 35         Europe Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)

Table 36         Europe Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)

Table 37         Asia-Pacific Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)

Table 38         Asia-Pacific Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)

Table 39         Asia-Pacific Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)

Table 40         Asia-Pacific Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)

Table 41         Asia-Pacific Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)

Table 42         Asia-Pacific Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)

Table 43         Middle East & Africa Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)

Table 44         Middle East & Africa Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)

Table 45         Middle East & Africa Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)

Table 46         Middle East & Africa Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)

Table 47         Middle East & Africa Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)

Table 48         Agilent Technologies, Inc: Overview

Table 49         Agilent Technologies, Inc: Product Portfolio

Table 50         Agilent Technologies, Inc: Key Developments

Table 51          F. Hoffmann-La Roche Ltd: Overview

Table 52         F. Hoffmann-La Roche Ltd: Product Portfolio

Table 53         F. Hoffmann-La Roche Ltd: Key Developments

Table 54         Foundation Medicine, Inc.: Overview

Table 55         Foundation Medicine, Inc.: Product Portfolio

Table 56         Foundation Medicine, Inc.: Key Developments

Table 57         HTG Molecular Diagnostics, Inc.: Overview

Table 58         HTG Molecular Diagnostics, Inc.: Product Portfolio

Table 59         HTG Molecular Diagnostics, Inc.: Key Developments

Table 60         Illumina, Inc.: Overview

Table 61         Illumina, Inc.: Product Portfolio

Table 62         Illumina, Inc.: Key Developments

Table 63         Merck KGaA: Overview

Table 64         Merck KGaA: Product Portfolio

Table 65         Merck KGaA: Key Developments

Table 66         NanoString Technologies, Inc.: Overview

Table 67         NanoString Technologies, Inc.: Product Portfolio

Table 68         NanoString Technologies, Inc.: Key Developments

Table 69         PerkinElmer Inc.: Overview

Table 70         PerkinElmer Inc.: Product Portfolio

Table 71          PerkinElmer Inc.: Key Developments

Table 72         Qiagen: Overview

Table 73         Qiagen: Product Portfolio

Table 74         Qiagen: Key Developments

Table 75         Sartorius AG: Overview

Table 76         Sartorius AG: Product Portfolio

Table 77         Sartorius AG: Key Developments

List of Figures

Figure 1          Global Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)

Figure 2         Global Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)

Figure 3         Global Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)

Figure 4         Global Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)

Figure 5         Global Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)

Figure 6         Global Immuno oncology assays Market Share, By Region, 2018 & 2027 (%)

Figure 7         Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 8         Global Immuno oncology assays Market Y-o-Y Growth, By Products & Equipment, 2018-2027 (%)

Figure 9         Consumables: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 10       Software: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 11        Global Immuno oncology assays Market Y-o-Y Growth, By Technology, 2018-2027 (%)

Figure 12       Immunoassay: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 13       PCR: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 14       NGS: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 15        Flow Cytometry: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 16       Others: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 17        Global Immuno oncology assays Market Y-o-Y Growth, By Application, 2018-2027 (%)

Figure 18       Clinical Diagnostics: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 19       Laparoscopic Surgery: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 20       Open tension repair: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 21       Global Immuno oncology assays Market Y-o-Y Growth, By Assay type, 2018-2027 (%)

Figure 22       cell proliferation assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 23       cell migration & invasion assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 24       phagocytosis assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 25       immune cell killing assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 26       Others: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 27       Global Immuno oncology assays Market Y-o-Y Growth, By Indication, 2018-2027 (%)

Figure 28       Colorectal Cancer: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 29       Lung Cancer: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 30       Melanoma: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 31       Bladder Cancer: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 32       Others: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 33       Global Immuno oncology assays Market Y-o-Y Growth, By Region, 2018-2027 (%)

Figure 34       North America Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 35       North America Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)

Figure 36       North America Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)

Figure 37       North America Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)

Figure 38       North America Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)

Figure 39       North America Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)

Figure 40       North America Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)

Figure 41       South America Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 42       South America Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)

Figure 43       South America Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)

Figure 44       South America Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)

Figure 45       South America Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)

Figure 46       South America Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)

Figure 47       South America Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)

Figure 48       Europe Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 49       Europe Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)

Figure 50       Europe Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)

Figure 51        Europe Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)

Figure 52       Europe Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)

Figure 53       Europe Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)

Figure 54       Europe Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)

Figure 55       Asia-Pacific Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 56       Asia-Pacific Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)

Figure 57       Asia-Pacific Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)

Figure 58       Asia-Pacific Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)

Figure 59       Asia-Pacific Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)

Figure 60       Asia-Pacific Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)

Figure 61       Asia-Pacific Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)

Figure 62       Middle East & Africa Immuno oncology assays Market Value, 2017-2027 ($ Million)

Figure 63 the Middle East & Africa Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)

Figure 64 the Middle East & Africa Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)

Figure 65 the Middle East & Africa Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)

Figure 66 the Middle East & Africa Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)

Figure 67 the Middle East & Africa Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)

Figure 68       Agilent Technologies, Inc: Financials

Figure 69       F. Hoffmann-La Roche Ltd: Financials

Figure 70       Foundation Medicine, Inc.: Financials

Figure 71        HTG Molecular Diagnostics, Inc.: Financials

Figure 72       Illumina, Inc.: Financials

Figure 73       Merck KGaA: Financials

Figure 74       NanoString Technologies, Inc.: Financials

Figure 75       PerkinElmer Inc.: Financials

Figure 76       Qiagen: Financials

Figure 77       Sartorius AG: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest

Our Research Experts are tracking the impact of COVID-19 on various domains across all industry verticals and our market reports are incorporated with these insights.